BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27391196)

Published in Transplantation on November 01, 2016

Authors

Caroline Lamarche1, Julie Orio, Suzon Collette, Lynne Senécal, Marie-Josée Hébert, Édith Renoult, Lee Anne Tibbles, Jean-Sébastien Delisle

Author Affiliations

1: 1 Centre de Recherche de l'Hôpital Maisonneuve-Rosemont (CRHMR), Montreal, Canada. 2 Division of Nephrology, Department of Medicine, Hôpital Maisonneuve-Rosemont (HMR), Université de Montréal, Montreal, Quebec, Canada. 3 Centre de recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montreal, Quebec, Canada. 4 Division of Nephrology, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, Quebec, Canada. 5 Faculty of Medicine, Institute of Infection, Immunity and Inflammation, University of Calgary, Calgary, AB, Canada. 6 Division of Hematology, Department of Medicine, Hôpital Maisonneuve-Rosemont (HMR), Université de Montréal, Montreal, Quebec, Canada.

Associated clinical trials:

Anti-BK Virus Immune Response and Kidney Transplantation (BKv) | NCT01109186

Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients | NCT01624948

Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant | NCT02049827

Role of Everolimus in Highly Sensitized Patients | NCT01911546

Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant (BKVIRUS) | NCT01289301

Articles citing this

BK viruria and viremia in children with systemic lupus erythematosus. Pediatr Rheumatol Online J (2017) 0.75

Articles cited by this

(truncated to the top 100)

New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet (1971) 12.13

Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant (2009) 6.43

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med (2002) 5.34

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood (2009) 4.98

Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis (1983) 3.89

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol (2003) 3.73

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Prevalence in England of antibody to human polyomavirus (B.k.). Br Med J (1973) 3.34

Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. JAMA (2014) 3.33

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis (2009) 3.23

A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med (1953) 3.01

Polyomavirus BK. Lancet Infect Dis (2003) 2.99

Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation (2002) 2.86

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76

The induction of neoplasms with a substance released from mouse tumors by tissue culture. Virology (1957) 2.67

Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med (1986) 2.47

High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis (1973) 2.40

A human papovavirus (B.K.), biological properties and seroepidemiology. Ann Clin Res (1973) 2.21

Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19

The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol (1982) 2.04

Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome. J Natl Cancer Inst (1974) 2.00

Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol (2002) 1.97

Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93

BK virus: opportunity makes a pathogen. Clin Infect Dis (2005) 1.90

BK polyomavirus in solid organ transplantation. Am J Transplant (2013) 1.83

Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology (1994) 1.70

BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model. Hum Pathol (2013) 1.67

Pathology of resolving polyomavirus-associated nephropathy. Am J Transplant (2013) 1.65

Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant (2007) 1.61

Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med (2008) 1.60

Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature. Am J Kidney Dis (1997) 1.59

Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol (2006) 1.58

HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity. Am J Transplant (2006) 1.56

Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology (1992) 1.52

Immune evasion of natural killer cells by viruses. Curr Opin Immunol (2008) 1.51

BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology (2004) 1.49

Urinary proinflammatory cytokine response in renal transplant recipients with polyomavirus BK viruria. Transplantation (2009) 1.47

Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol (2004) 1.46

The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients. Kidney Int (2013) 1.44

BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant (2010) 1.43

Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant (2012) 1.42

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med (2014) 1.40

The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood (2007) 1.39

Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol (1978) 1.37

Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol (1993) 1.37

Reactivation of polyoma virus in kidneys of persistently infected mice during pregnancy. Infect Immun (1979) 1.36

Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate (2002) 1.36

Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. J Clin Microbiol (1994) 1.34

Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant (2010) 1.33

Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation (2005) 1.32

An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation (2009) 1.31

An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe (2011) 1.28

BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant (2003) 1.28

Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol (1993) 1.27

BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis (1994) 1.25

BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol (2008) 1.25

Polyomavirus BK-specific immunity after kidney transplantation. Transplantation (2004) 1.22

Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. Transplantation (2009) 1.21

Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation. Clin Exp Immunol (1983) 1.20

Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med (1983) 1.17

Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation (2007) 1.17

The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol (1997) 1.16

The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry. Virology (2009) 1.15

Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation (2002) 1.14

BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy. Am J Transplant (2011) 1.09

Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation (2003) 1.06

Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation (2008) 1.05

Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol (2009) 1.04

Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation (2010) 1.02

Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation (2008) 1.02

Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation (2010) 1.02

Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunol (2007) 1.01

Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation (2001) 1.01

Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res (2011) 1.01

Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant (2004) 1.00

Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant (2005) 1.00

Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation (2010) 0.99

Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy. Clin Transplant (2001) 0.99

Interobserver agreement for Polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology. Hum Pathol (2011) 0.99

HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant (2004) 0.99

High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2014) 0.98

Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones. Antivir Ther (2007) 0.97

BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant (2005) 0.96

Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer (2007) 0.96

Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. J Gen Virol (2000) 0.95

BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis (1999) 0.95

A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis (1988) 0.94

Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci (2007) 0.94

Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation (2010) 0.93

Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant (2014) 0.93

Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol (2014) 0.92

BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses. Transplantation (2011) 0.92

BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis. Am J Kidney Dis (2002) 0.92

ERAD and how viruses exploit it. Front Microbiol (2014) 0.91

A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J Virol (1994) 0.91

Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation. Br J Cancer (2008) 0.91

Stimulation of BK virus DNA replication by NFI family transcription factors. J Virol (2011) 0.91

Articles by these authors

Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol (2008) 1.65

Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes. Am J Cardiol (2010) 1.51

The enigmatic nature of altruism in organ transplantation: a cross-cultural study of transplant physicians' views on altruism. BMC Res Notes (2010) 1.27

Role of enteric glia in intestinal physiology: effects of the gliotoxin fluorocitrate on motor and secretory function. Am J Physiol Gastrointest Liver Physiol (2006) 1.19

Predictors and outcome of cardiopulmonary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year period. Nephrol Dial Transplant (2005) 1.17

Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism. Transplantation (2010) 1.13

Perlecan proteolysis induces an alpha2beta1 integrin- and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J Biol Chem (2006) 1.11

T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med (2005) 1.06

Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J Biol Chem (2008) 1.05

Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am J Transplant (2004) 0.98

Caspase activation regulates the extracellular export of autophagic vacuoles. Autophagy (2012) 0.97

ROS generation in endothelial hypoxia and reoxygenation stimulates MAP kinase signaling and kinase-dependent neutrophil recruitment. Free Radic Biol Med (2007) 0.96

Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells. Stem Cells (2010) 0.95

Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor. Biochem Biophys Res Commun (2005) 0.95

Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF. Autophagy (2014) 0.95

Modifiable factors predicting patient survival in elderly kidney transplant recipients. Kidney Int (2005) 0.94

Are 'anonymous' and 'non-directed' prerequisites for living altruistic donation? The views of transplant physicians from France and Québec. Soc Sci Med (2008) 0.94

Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats. Drug Metab Dispos (2011) 0.94

Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation (2010) 0.93

Akt/protein kinase B activation by adenovirus vectors contributes to NFkappaB-dependent CXCL10 expression. J Virol (2005) 0.93

The use of personalized medicine for patient selection for renal transplantation: physicians' views on the clinical and ethical implications. BMC Med Ethics (2010) 0.93

Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis. J Immunol (2005) 0.93

Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. J Clin Invest (2014) 0.92

Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit? Kidney Int Suppl (2002) 0.91

Impact of stress, distress and feelings of indebtedness on adherence to immunosuppressants following kidney transplantation. Clin Transplant (2006) 0.91

Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on VSMC. FASEB J (2004) 0.91

Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop. Pediatr Nephrol (2007) 0.90

The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design. Nephrol Dial Transplant (2007) 0.89

Soluble fibronectin induces chemokine gene expression in renal tubular epithelial cells. Kidney Int (2005) 0.87

The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. Circ Res (2011) 0.86

Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol (2007) 0.85

LNA-based oligonucleotide electrotransfer for miRNA inhibition. Mol Ther (2012) 0.84

Blockade of the apoptotic machinery by cyclosporin A redirects cell death toward necrosis in arterial endothelial cells: regulation by reactive oxygen species and cathepsin D. FASEB J (2003) 0.84

Electric field-assisted delivery of photofrin to human breast carcinoma cells. J Membr Biol (2013) 0.83

T cell activation leads to protein kinase C theta-dependent inhibition of TGF-beta signaling. J Immunol (2010) 0.83

Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer. Front Immunol (2013) 0.82

IL-4 primes human endothelial cells for secondary responses to histamine. J Leukoc Biol (2003) 0.81

Differences in psychosocial profiles between men and women living kidney donors. Clin Transplant (2007) 0.81

Uraemic plasma decreases the expression of ABCA1, ABCG1 and cell-cycle genes in human coronary arterial endothelial cells. Nephrol Dial Transplant (2006) 0.81

Use of a minimally invasive donor nephrectomy program to select technique for live donor nephrectomy. Am J Surg (2005) 0.81

Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C. Am J Physiol Cell Physiol (2009) 0.81

Ischemia/reperfusion induces the recruitment of leukocytes from whole blood under flow conditions. Free Radic Biol Med (2004) 0.80

Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians. Drug Metab Pharmacokinet (2010) 0.80

Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients. Nephrol Dial Transplant (2002) 0.80

MAP kinase activation increases BK polyomavirus replication and facilitates viral propagation in vitro. J Virol Methods (2010) 0.79

SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage. Blood (2010) 0.79

Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients. Hemodial Int (2005) 0.78

Paracrine repercussions of preconditioning on angiogenesis and apoptosis of endothelial cells. Biochem Biophys Res Commun (2002) 0.78

The incidence, management, and evolution of rapamycin-related side effects in kidney transplant recipients. Clin Transplant (2014) 0.78

Soluble Fas: a novel predictor of atherosclerosis in dialysis patients. Am J Kidney Dis (2003) 0.77

Chondroitin-4-sulfate: a bioactive macromolecule to foster vascular healing around stent-grafts after endovascular aneurysm repair. Macromol Biosci (2007) 0.77

Versatile cellular uptake mediated by catanionic vesicles: simultaneous spontaneous membrane fusion and endocytosis. Mol Pharm (2014) 0.77

Human pregnancy and generation of anti-angiotensin receptor and anti-perlecan antibodies. Transpl Int (2014) 0.77

A clinical scalable cryopreservation method of adipose tissue for reconstructive surgery assessed by stromal vascular fraction and mice studies. Plast Reconstr Surg (2014) 0.77

Nitrogen-rich coatings for promoting healing around stent-grafts after endovascular aneurysm repair. Biomaterials (2007) 0.77

Roles of transforming growth factor-β in graft-versus-host and graft-versus-tumor effects. Biol Blood Marrow Transplant (2012) 0.77

Prolongation of human neutrophil survival by low-level mercury via inhibition of spontaneous apoptosis. J Toxicol Environ Health A (2002) 0.76

Stimulation of cell growth and resistance to apoptosis in vascular smooth muscle cells on a chondroitin sulfate/epidermal growth factor coating. Biomaterials (2010) 0.76

Public Solicitation of Anonymous Organ Donors: A Position Paper by the Canadian Society of Transplantation. Transplantation (2017) 0.75

The apoptotic program promotes tissue remodeling and fibrosis. Kidney Int (2011) 0.75

[New hopes for cancer immunotherapy]. Med Sci (Paris) (2006) 0.75

Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature. Exp Clin Transplant (2014) 0.75

Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive Immunotherapy. Transplantation (2017) 0.75

Mycobacterium genavense and chronic intermittent diarrhea in a kidney and pancreas transplant recipient. Transplantation (2013) 0.75

Why are Quebec's doctors leaving? CMAJ (2002) 0.75

Treatment of Polyomavirus-Associated Nephropathy With the Association of Sirolimus and Leflunomide. Exp Clin Transplant (2015) 0.75

New answers to old conundrums: what antibodies, exosomes and inflammasomes bring to the conversation. Canadian National Transplant Research Program international summit report. Transplantation (2017) 0.75

Difficulty of patient selection in a combined heart-kidney transplant: a case report. Exp Clin Transplant (2014) 0.75

Enhanced development of caspase-independent cortical cell death during cold storage in kidneys of non-heart-beating donors. Transplantation (2002) 0.75

Cyanines in photodynamic reaction assisted by reversible electroporation--in vitro study on human breast carcinoma cells. Photodiagnosis Photodyn Ther (2013) 0.75

Chondroitin sulfate and epidermal growth factor immobilization after plasma polymerization: a versatile anti-apoptotic coating to promote healing around stent grafts. Macromol Biosci (2012) 0.75

Complement factor H deficiency in acute allograft glomerulopathy and post-transplant hemolytic uremic syndrome. Am J Transplant (2004) 0.75

Influence of SLCO1B3 genetic variations on tacrolimus pharmacokinetics in renal transplant recipients. Drug Metab Pharmacokinet (2012) 0.75

Varicella Zoster Virus Vasculopathy After Kidney Transplantation. Transplantation (2016) 0.75